Regulation of Megakaryocytopoiesis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Pathophysiology of Haemostasis and Thrombosis

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000022458PMID 10494032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide

  1999cited by this paper
• An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia

  1998cited by this paper
• New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides.

  1998cited by this paper
• Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

  1998cited by this paper
• Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine.

  1997cited by this paper
• Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia

  1997cited by this paper
• 2 Positive and negative regulation of megakaryocytopoiesis

  1997cited by this paper
• Positive and negative regulation of megakaryocytopoiesis.

  1997cited by this paper
• Thrombopoietin-induced Polyploidization of Bone Marrow Megakaryocytes Is Due to a Unique Regulatory Mechanism in Late Mitosis

  1997cited by this paper
• Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis.

  1997cited by this paper
• Thrombopoietin: understanding and manipulating platelet production.

  1997cited by this paper
• The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis

  1996cited by this paper
• Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.

  1996cited by this paper
• Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor β1

  1996cited by this paper
• Inhibitory effect of platelet factor 4 on human erythroleukemic cells is dependent on cell surface heparan sulfate.

  1996cited by this paper
• Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators

  1996cited by this paper
• Carboxy‐terminal peptides (C1–24 and C13–24 but not C1–13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin

  1996cited by this paper
• Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer.

  1996cited by this paper
• Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

  1996cited by this paper
• Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

  1995cited by this paper
• Chemokine regulation of human megakaryocytopoiesis.

  1995cited by this paper
• Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.

  1995cited by this paper
• Thrombopoietin: the primary regulator of platelet production.

  1995cited by this paper
• The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.

  1995cited by this paper
• Purification and characterization of thrombopoietin.

  1995cited by this paper
• Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.

  1995cited by this paper
• Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

  1994cited by this paper
• c-Mpl ligand is a humoral regulator of megakaryocytopoiesis

  1994cited by this paper
• Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand

  1994cited by this paper
• Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor

  1994cited by this paper
• The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.

  1994cited by this paper
• Thrombocytopenia in c-mpl-deficient mice.

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI

  1994cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Carboxyl‐terminal Heparin‐binding Fragments of Platelet Factor 4 Retain the Blocking Effect on the Receptor Binding of Basic Fibroblast Growth Factor

  1993cited by this paper
• Control of megakaryocyte development: from basic data to clinical results.

  1993cited by this paper
• In vivo effects of recombinant interleukin-11 on myelopoiesis in mice.

  1993cited by this paper
• Megakaryocyte proplatelet-like process formation in vitro is inhibited by serum prothrombin, a process which is blocked by matrix-bound glycosaminoglycans.

  1993cited by this paper
• Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells.

  1993cited by this paper
• Control of megakaryocyte development: from basic data to clinical results.

  1993cited by this paper
• Effect of recombinant human interleukin‐11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin‐6

  1993cited by this paper
• Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.

  1993cited by this paper
• Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture.

  1992cited by this paper
• In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates.

  1992cited by this paper
• Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans.

  1992cited by this paper
• Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment.

  1992cited by this paper
• Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.

  1992cited by this paper
• Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells.

  1992cited by this paper
• Interleukin-11 enhances human megakaryocytopoiesis in vitro.

  1992cited by this paper
• Expression of fibroblast growth factor receptors in human leukemia cells.

  1992cited by this paper
• In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors.

  1992cited by this paper
• Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil.

  1992cited by this paper
• Transient effect of erythropoietin on thrombocytopoiesis in vivo in mice.

  1992cited by this paper
• Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.

  1992cited by this paper
• Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture.

  1992cited by this paper
• Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells.

  1992cited by this paper
• Leukemia inhibitory factor and interleukin‐11 promote maturation of murine and human megakaryocytes in vitro

  1992cited by this paper
• New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.

  1992cited by this paper
• Transforming growth factor beta inhibits megakaryocyte growth and endomitosis.

  1992cited by this paper
• A dual receptor system is required for basic fibroblast growth factor activity.

  1991cited by this paper
• Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro.

  1991cited by this paper
• Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells.

  1991cited by this paper
• The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia.

  1991cited by this paper
• Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.

  1991cited by this paper
• In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice.

  1991cited by this paper
• A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors.

  1990cited by this paper
• Hematologic and Hematopoietic Changes Induced by Systemic Administration of TGFβ1

  1990cited by this paper
• TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

  1990cited by this paper
• TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights

  1990cited by this paper
• In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor.

  1990cited by this paper
• In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

  1990cited by this paper
• Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura

  1990cited by this paper
• Preliminary report: effects of interleukin-1 on platelet counts

  1990cited by this paper
• Effect of recombinant granulocyte-macrophage colony-stimulating factor on murine thrombocytopoiesis in vitro and in vivo

  1990cited by this paper
• Effect of recombinant granulocyte-macrophage colony-stimulating factor on murine thrombocytopoiesis in vitro and in vivo.

  1990cited by this paper
• Platelet factor 4 inhibits human megakaryocytopoiesis in vitro.

  1990cited by this paper
• Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6.

  1990cited by this paper
• Interleukin-6 is a potent thrombopoietic factor in vivo in mice.

  1989cited by this paper
• Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

  1989cited by this paper
• Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates.

  1988cited by this paper
• Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation.

  1987cited by this paper
• Platelets Generated in Vitro from Proplatelet-displaying Human Megakaryocytes Are Functional Isolation of Cd34+ Progenitor Cells from Peripheral Blood

  year unknowncited by this paper

• Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF‐κB/SMAD pathway in patients with immune thrombocytopenia

  2018cites this paper
• A novel mode of stimulating platelet formation activity in megakaryocytes with peanut skin extract

  2017cites this paper
• PF4 Promotes Platelet Production and Lung Cancer Growth.

  2016cites this paper
• Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy

  2015cites this paper
• The Effect of Bleeding on Hematopoietic Stem Cell Cycling and Self-Renewal

  2007cites this paper
• CD41+/CD45+ Cells Without Acetylcholinesterase Activity Are Immature and a Major Megakaryocytic Population in Murine Bone Marrow

  2007cites this paper
• Chapter 23 – Platelets and Related Products

  2007cites this paper
• The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells.

  2007cites this paper
• Mechanisms of HDAC inhibitor-induced thrombocytopenia.

  2007cites this paper
• Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells

  2006cites this paper
• Roles of platelet factor 4 in hematopoiesis and angiogenesis

  2006cites this paper
• A Phase I Clinical, Pharmacologic, and Biologic Study of Thrombopoietin and Granulocyte Colony-Stimulating Factor in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Recurrent or Refractory Solid Tumors: A Children's Oncology Group Experience

  2005cites this paper
• NMDA receptor-mediated regulation of human megakaryocytopoiesis.

  2003cites this paper
• Molecular and Cellular Biology of Moderate-Dose (1–10 Gy) Radiation and Potential Mechanisms of Radiation Protection: Report of a Workshop at Bethesda, Maryland, December 17–18, 20011

  2003cites this paper
• Development of a liquid culture system for megakaryocyte terminal differentiation: fibrinogen promotes megakaryocytopoiesis but not thrombopoiesis

  2003cites this paper
• Plasma Transforming Growth Factor β1 Levels in Thrombocytopenic and Nonthrombocytopenic Neonates

  2003cites this paper
• Impact of pretreatment thrombocytosis on survival in primary breast cancer

  2003cites this paper
• Review: Role of Blood Platelets in Infection and Inflammation

  2002cites this paper
• Expression and function of NJ-1 surface antigen in megakaryopoiesis.

  2002cites this paper
• An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.

  2001cites this paper
• Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production.

  2001cites this paper
• Thyroid Function and Thyroid Hormone Requirements of Very Preterm Infants

  2000cites this paper
• Differentially Expressed Genes Using Genomic Expression Profiles An Efficient and Robust Statistical Modeling Approach to Discover

  year unknowncites this paper